Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation

Journal of Perinatology

Volumn 25, Issue 2, 2005, Pages 86-89

  Motta, Mario ^a   Tincani, Angela ^b   Faden, David ^c   Zinzini, Enrica ^d   Lojacono, Andrea ^c   Marchesi, Alessandra ^a   Frassi, Micol ^b   Biasini, Chiara ^b   Zatti, Sonia ^c   Chirico, Gaetano ^a  

^a Division of Neonatology   (Italy)

^b Rheumatology and Clinical Immunology Service   (Italy)

^c Obstetrics and Gynecology   (Italy)

^d Division of Ophthalmology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOQUINOLINE DERIVATIVE; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN A; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ARTICLE; BREAST FEEDING; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; LACTATION; MATERNAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN INFECTION; OUTCOMES RESEARCH; PERINATAL DRUG EXPOSURE; PREGNANCY; PREMATURE LABOR; PREMATURITY; PROSPECTIVE STUDY; RHEUMATIC DISEASE; VISION;

ANTIRHEUMATIC AGENTS; BREAST FEEDING; CHILD DEVELOPMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RHEUMATIC DISEASES;

EID: 20944448673     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211208     Document Type: Article

References (19)

1. Fox RI. Antimalarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus 1996;5(Suppl 1):4-10.
2. Ulberg S, Lindquist NG, Sjostrand SE. Accumulation of chorioretinotoxic drugs in foetal eye. Nature 1970;227:1257-8.
3. Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001;358:813-4.
4. Hart CW, Naunton RF. The ototoxicity of chloroquine phosphate. Arch Otolaryngol Head Neck Surg 1964;80:407-12.
5. Esdaile JM, Koehler BE, Suarez-Alzamor ME, et al. Canadian consensus conference on hydroxychloroquine. J Rheumatol 2000;27:2919-21.
6. Parke AL, Rothfield NF. Antimalarial drugs in pregnancy: the North American experience. Lupus 1996;5(Suppl 1):67-9.
7. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 2003;36:51-6.
8. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-89.
9. Ostensen M, Brown ND, Chiang PK, Aarbakke J. Hydroxychloroquine in human breast milk. Eur J Clin Pharmacol 1985;28:357.
10. Nation RL, Hackett LP, Dusci LJ, Ilett KF. Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol 1984;17:368-9.
11. Capute AJ, Shapiro BK. The motor quotient: a method for early determination of motor delay. Am J Dis Child 1985;139:940-2.
12. Costedoat-Chalumeau N, Amoura Z, Aymard G, et al. Evidence of transplacental passage of hydroxychloroquine (HCQ) in humans. Arthritis Rheum 2001;44:1123-4.
13. Wallace DJ. Antimalarial agents and lupus. Rheum Dis Clin North Am 1994;20:243-63.
14. Motta M, Tincani A, Faden D, Zinzini E, Chirico G. Antimalarial agents in pregnancy. Lancet 2002;359:524-5.
15. Levy M, Buskila D, Gladman DD, Urowiz MB, Koren G. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 1991;8:174-8.
16. Khamashta MA, Buchanan NM, Hughes GR. The use of hydroxychloroquine in lupus pregnancy: the British experience. Lupus 1996;5(Suppl 1): 65-6.
17. Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. A study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003;48:3207-11.
18. Levy RA, Vilela VS, Cataldo, MJ, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001;10: 401-4.
19. Airò P, Antonioli CM, Motta M, et al. The immune development in a child born to cyclosporin A-treated woman with systemic lupus erythematous/polymyositis. Lupus 2002;11:454-7.